Ashland Inc. (ASH)
| Market Cap | 3.41B +31.8% |
| Revenue (ttm) | 1.84B -1.4% |
| Net Income | 52.00M |
| EPS | 1.15 |
| Shares Out | 45.79M |
| PE Ratio | 44.87 |
| Forward PE | 18.15 |
| Dividend | $1.68 (2.26%) |
| Ex-Dividend Date | Sep 1, 2026 |
| Volume | 469,395 |
| Open | 74.55 |
| Previous Close | 73.94 |
| Day's Range | 73.07 - 75.10 |
| 52-Week Range | 46.30 - 78.25 |
| Beta | 0.39 |
| Analysts | Buy |
| Price Target | 80.18 (+7.81%) |
| Earnings Date | Jul 28, 2026 |
About ASH
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemi... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 12 analysts, the average rating for ASH stock is "Buy." The 12-month stock price target is $80.18, which is an increase of 7.81% from the latest price.
News
Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate
WILMINGTON, Del., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), is announcing the launch of permexa™ sodium caprate, a high-performance intestinal permeation enhancer designed to support...
Ashland price in low/mid-$90s ‘likely gets a deal done,’ says Wolfe Research
Wolfe Research notes Bloomberg suggests that Ashland (ASH) is pursuing a potential sale process after receiving takeover interest. Despite persistent shareholder pressures, the firm doesn’t believe As...
Ashland board authorizes quarterly dividend
WILMINGTON, Del., Aug. 07, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.42 cents per share on the company's common stock.
Ashland working with banks to explore potential sale, Bloomberg says
Ashland (ASH) is exploring a potential sale after receiving takeover interest, Ryan Gould, Liana Baker, Kiel Porter and Mengqi Sun of Bloomberg report, citing people familiar with the matter. The…
Ashland exploring sale after takeover interest, Bloomberg reports
15:57 EDT Ashland (ASH) exploring sale after takeover interest, Bloomberg reports
Ashland jumps 4% to $75.69 after Bloomberg report of takeover interest
15:57 EDT Ashland (ASH) jumps 4% to $75.69 after Bloomberg report of takeover interest
Ashland price target raised to $78 from $58 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Ashland (ASH) to $78 from $58 and keeps an Equal Weight rating on the shares. The firm said its new price target…
Ashland price target raised to $85 from $74 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Ashland (ASH) to $85 from $74 and keeps a Buy rating on the shares.
Ashland price target raised to $83 from $75 at UBS
UBS raised the firm’s price target on Ashland (ASH) to $83 from $75 and keeps a Buy rating on the shares.
Ashland price target raised to $80 from $75 at JPMorgan
JPMorgan raised the firm’s price target on Ashland (ASH) to $80 from $75 and keeps an Overweight rating on the shares.
Ashland price target raised to $73 from $60 at Evercore ISI
Evercore ISI raised the firm’s price target on Ashland (ASH) to $73 from $60 and keeps an In Line rating on the shares.
Ashland Earnings Call Transcript: Q3 2026
Third quarter sales grew 7% year-over-year, led by strong volume gains in Life Sciences and Personal Care, while operational improvements and pricing actions supported sequential profitability. Fiscal 2026 guidance was reaffirmed, with further margin recovery expected in Q4.
Ashland Earnings release: Q3 2026
Ashland released its Q3 2026 earnings on July 29, 2026, summarizing the period's financial results.
Ashland Slides: Q3 2026
Ashland has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on July 29, 2026.
Ashland Quarterly report: Q3 2026
Ashland has published its Q3 2026 quarterly earnings report on July 29, 2026.
Ashland price target raised to $75 from $68 at BMO Capital
BMO Capital analyst John McNulty raised the firm’s price target on Ashland (ASH) to $75 from $68 and keeps an Outperform rating on the shares. The company posted a respectable…
Ashland price target raised to $77 from $75 at Mizuho
Mizuho raised the firm’s price target on Ashland (ASH) to $77 from $75 and keeps an Outperform rating on the shares.
Ashland reports Q3 adjusted EPS $1.02, consensus 98c
Reports Q3 revenue $497M, consensus $485.98M. “Ashland’s (ASH) Q3 results reflected broad-based demand and strong commercial execution across the portfolio,” said Guillermo Novo, chair and CEO, Ashlan...
Ashland reaffirms FY26 revenue view $1.835B-$1.870B, consensus $1.85B
Reaffirms FY26 Adjusted EBITDA $385M-$400M; a Adjusted Diluted EPS excluding intangibles amortization low-to-mid single-digit growth; and ongoing free cash flow conversion greater than 50% of Adjusted...
Ashland reports third quarter 2026 results and reaffirms full-year sales & Adjusted EBITDA outlook
Sales of $497 million, up seven percent from the prior-year quarter Income from continuing operations of $41 million, or $0.89 per diluted share Adjusted Income from Continuing Operations Excluding In...
Ashland announces appointment of two new directors as part of Cooperation Agreement with stockholder Ancora
WILMINGTON, Del., July 28, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), a global leader in additives and specialty ingredients, today announced the appointments of two new independent members of...
Ashland near settlement with activist Ancora, Bloomberg reports
Ashland (ASH) is nearing a settlement with activist Ancora that would expand the company’s board of directors, Mengqi Sun, Ryan Gould and Liana Baker of Bloomberg report, citing people familiar…
Wolfe Research boosts Ashland price target, cites activist pressures
Wolfe Research raised the firm’s price target on Ashland (ASH) to $78 from $66 and keeps an Outperform rating on the shares. Wolfe Research told investors that Ashland needs to…
Ashland sets date for third-quarter fiscal 2026 earnings release and conference call webcast
WILMINGTON, Del., July 14, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its third-quarter fiscal 2026 earnings release at approximately 5 p.m.
Ashland price target raised to $75 from $65 at JPMorgan
JPMorgan raised the firm’s price target on Ashland (ASH) to $75 from $65 and keeps an Overweight rating on the shares. The firm’s increased price target reflects higher EBITDA levels…